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pH regulationThe mammalian Na+/H+ exchanger isoform 1 (NHE1) is an integral membrane protein that regulates
intracellular pH (pHi) by removing one intracellular H+ in exchange for one extracellular Na+. It has a large
500 amino acid N-terminal membrane domain that mediates transport and consists of 12 transmembrane
segments and several membrane-associated segments. Extracellular regions of this domain are believed to
contribute to cation coordination, transport and sensitivity to inhibitors. In this study we characterized the
structure and function of extracellular loop 2. Mutation of residues Pro153, Pro154 and Phe155
demonstrated that these residues were critical for efﬁcient NHE1 function. Mutations to Ala resulted in
decreases in cation afﬁnity and in decreases in activity of the protein, these were more marked in both
Pro154 and Phe155. NMR spectroscopy was used to characterize the solution structure of a peptide NAc-
Gly150-Phe155-NH2. The peptide showed at least three different conformers in solution due to cis–trans
isomerization of the Thr152–Pro153 and Pro153–Pro154 peptide bonds. The trans–trans conformation appeared
to be in an extended conformation, whereas the cis–trans conformation showed a propensity to form a beta
turn. Our results show that the EL2 region is critical to NHE1 function and that a peptide of the EL2 region can
adopt different structures in solution potentially forming a beta turn that is important in function of the full
protein Mutation of Pro154 could disrupt the beta turn, affecting helix packing and the protein structure and
function.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
The mammalian Na+/H+ exchanger isoform 1 is a ubiquitous
integral membrane protein that regulates pHi by mediating removal
of one intracellular proton in exchange for one extracellular sodium
ion [1]. NHE1 thereby functions to remove excess intracellular acid
while facilitating Na+ entry into the cytosol [1]. Ten known isoforms
of the Na+/H+ exchanger are designated NHE1-NHE10, [2,3]. NHE2-
10 havemore restricted tissue distributions than NHE1 and some have
predominantly intracellular localizations (reviewed in [1]). Mamma-
lian NHE1 plays a key role in regulation of cell pH, cell volume, and cell
proliferation; and in metastasis of some kinds of tumor cells [1,4]. It
also promotes cell growth and differentiation [5], is critical to cell
motility in some cell types [6], and regulates sodium ﬂuxes and cell
volume after challenge by osmotic shrinkage [7]. The Na+/H+
exchanger also plays a critical causal role in heart hypertrophy and
in the damage that occurs during heart ischemia and reperfusion.
Inhibition of the exchanger with Na+/H+ exchanger inhibitors
protects the myocardium [8–10].
Although the exact mechanisms of transport and inhibitor binding
by NHE1 are not known, speciﬁc residues within several regions of the
membrane domain as well as several extracellular loops and+1 780 492 0886.
ll rights reserved.membrane-associated segments of NHE1 have been implicated as
being important for ion binding and transport [reviewed in [2]]. The
membrane-associated segment (EL5) is involved in the drug
sensitivity and cation binding and transport [2,11]. Loop regions
between α-helices can inﬂuence their arrangements and packing [12]
and extracellular loops of membrane proteins have been shown to
modulate their function [13].
TM IV immediately follows EL2 (Fig. 1). Numerous residues of TM
IV have been implicated in NHE1 function and the extramembrane
loops at either end of TM IV contain residues that are important for
NHE1 function. Early experiments showed that three residues of EL2
affect both the drug sensitivity and the activity of the exchanger [14].
IL2, at the C-terminal end of TM IV, contains residues that may line
the ion-transport pore and when mutated to Cys Arg180 and Gln181
are accessible by externally applied MTSET [15]. Recently, we
determined the structure of TM IV which was predominantly not
alpha helical, though structured [16]. Phe161, in the extracellular
side of the bilayer, was a pore lining residue and Pro residues in the
middle of the bilayer were critical to function [16,17]. However, in
those studies we did not examine the preceding EL2. In this study we
characterize EL2 in detail. We examined individual amino acids of
this extracellular loop and their contribution to differential drug
cation sensitivity and cation coordination. In addition we present the
ﬁrst NMR solution structure of an extracellular loop of a mammalian
Na+/H+ exchanger.
Fig. 1.Model of the NHE1 isoform of the Na+/H+ exchanger. The right panel indicates the topology of the Na+/H+ exchanger isoform 1 [15] while the left side is an enlargement of
illustrating amino acids of TM III-EL2-TM IV.
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2.1. Materials
PWO DNA polymerase was from Roche Molecular Biochemicals,
Mannheim, Germany. LIPOFECTAMINE™ 2000 Reagent was from
Invitrogen Life Technologies, Carlsbad, CA, USA. Anti-HA-antibody
was from Santa Cruz Biotechnology (Santa Cruz, CA). BCECF-AM was
from Molecular Probes, Inc. (Eugene, OR). All other chemicals were of
analytical grade and were purchased from Fisher Scientiﬁc (Ottawa,
ON), Sigma or BDH (Toronto, ON). EMD87580 was a generous gift of
Merck, Darmstadt, Germany.
2.2. Site-directed mutagenesis
Mutations were made to an expression plasmid containing a
tagged human NHE1 isoform of the Na+/H+ exchanger. The plasmid
pYN4+ contains the cDNA of the entire coding region of human
NHE1. It has a C-terminal hemagglutinin (HA) tag that we have
previously shown does not affect activity [16]. PWO DNA polymerase
(Roche Molecular Biochemicals, Mannheim, Germany) was used for
ampliﬁcation and site-directed mutagenesis was performed using the
Stratagene (La Jolla, CA, USA) QuikChange™ site directedmutagenesis
kit as recommended by the manufacturer. Mutations changed the
indicated amino acids to alanine and were designed to create or
remove a new restriction enzyme site for use in screening transfor-
mants (Table 1). The ﬁdelity of DNA ampliﬁcation was conﬁrmed by
DNA sequencing.Table 1
Oligonucleotide primers for site-directed mutagenesis.
Mutation Sequence
Pro153Ala 5′GGTGTAGGCGAGACggCgCCCTTC
Pro154Ala 5′GGTGTAGGCGAGACgCCggCCTTC
Phe155Ala 5′GGTGTAGGCGAGACACCCCCCgc
Mutated nucleotides are in lower case letters. Mutated codons are indicated in bold. Restricti
primer pair is illustrated.2.3. Cell culture and stable transfection
Stable cell lines of allmutantsweremadeasdescribed earlier [17] via
transfection with LIPOFECTAMINE™ 2000 Reagent (Invitrogen Life
Technologies, Carlsbad, CA,USA). AP-1 cells are a Chinese hamster ovary
cell line that lacks an endogenous Na+/H+ exchanger. They were used
to examine NHE1 activity and were routinely grown in a humidiﬁed
atmosphere of 5% CO2 and 95% air in α-MEM supplemented with 10%
(v/v) bovine growth serum, 25 mM Hepes, penicillin (100 U/ml) and
streptomycin (100 μg/ml), pH 7.4 at 37 °C. The transfection and
selection of stable cell lines was carried out as described previously and
transfection was done with LIPOFECTAMINE™ 2000 Reagent [16].
Brieﬂy, 1.0×106 cellswere seeded in 60mmPetri dish, in 4mlof growth
media. Cells were grown until 90% conﬂuent and transfectedwith 10 μg
of wild type or mutant plasmids. Post-transfection cells were trypsi-
nized, diluted 10 or 100 times with α-MEM medium and plated in
100 mm dishes in α-MEM media containing 800 μg/ml geneticin
(G418) thatwas used tomaintain selection pressure without acute acid
load selection. After the initial selection, single clones of transfected cells
were obtained and stable cell lines weremaintained in 400 μg/ml G418
and were regularly re-established from frozen stocks at passage
numbers between 5 and 15. Results shown are from at least two
independently obtained clones for each mutant cell line.
2.4. SDS-PAGE and immunoblotting
Western blot analysis was used to conﬁrm NHE1 expression [17].
For eachWestern blot, 100 μg of each total lysate was resolved on 10%Site
CTGCAGTCCGAC3′ NarI
CTGCAGTCCGACGTCTTC3′ NaeI
CCTaCAGTCCGACGTCTTCTTCCTC3′ −PstI
on sites removed (−) or added are underlined. In each case the forward direction of the
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Immunoblot analysis with anti-HA antibody tag conﬁrmed NHE1
expression in samples of cell lysates of transfected AP-1 cells [17]. The
Amersham enhanced chemiluminescence Western blotting and
detection system was used to detect immunoreactive proteins.
Densitometric analysis of X-ray ﬁlms was carried out using NIH
Image software (National Institutes of Health, Bethesda, MD, USA).
2.5. Cell surface expression
Cell surface expression was measured as described earlier [16,17]
to ensure that all mutant proteins were properly targeted to the cell
surface. Cells were labeled with Sulpho-NHS-SS-Biotin (Pierce
Chemical Company, Rockford, IL, USA) and immobilized streptavidin
resin was used to remove surface labeled Protein Equal amounts of
the total and unbound proteins were analyzed by 10% SDS-PAGE
followed by Western blotting against the HA tag. Relative amounts of
NHE1 on the cell surface were calculated by comparing both the 110-
kDa and the 95-kDa forms of NHE1 in the total and unbound fractions.
It was not possible to efﬁciently elute biotin labeled proteins bound to
immobilized streptavidin resin for direct measurement of extracellu-
lar NHE1 protein.
2.6. Na+/H+ exchange activity
NHE1 activity was measured using a PTI Deltascan spectroﬂuo-
rometer as described earlier [18]. Stably transfected cells were
seeded on glass coverslips (2×105 cells per coverslip) and grown
until they reached 80–90% conﬂuency. The coverslip was then
transferred to a cuvette holder with constant stirring at 37 °C. The
cells were loaded with 0.15 μg/ml 2′,7-bis (2-carboxyethyl)-5 (6)
carboxyﬂuorescein-AM (BCECF-AM) and incubated in “Normal
buffer” containing 135 mM NaCl, 5 mM KCl, 1 mM MgCl2, 1.8 mM
CaCl2, 5.5 mM glucose, and 10 mM HEPES, pH 7.4 at 37 °C. Normal
buffer is nominally bicarbonate free. Intracellular acidosis was
induced by NH3/NH4+ prepulse/withdrawal (3 min in “Normal
buffer” containing 50 mM NH4Cl, pH 7.4), followed by withdrawal
for 30 sec in “Na+-free buffer”: (135 mM N-methyl-D-glucamine,
5 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5.5 mM glucose, and 10 mM
HEPES, pH 7.4). Intracellular pH (pHi) recovery was in “Normal
buffer” allowing the cells to recover for at least 3 min. There were
no differences in buffering capacities of stable cell lines (not
shown). Following pHi recovery for every experiment a three-
point pH calibration curve was made using the K+/nigericin method
with Na+-free calibration buffers (5 mM N-methyl-D-glucamine,
135 mM KCl, 1.8 mM CaCl2, 1 mM MgSO4, 5.5 mM glucose, 10 mM
HEPES, at pH 6, 7, and 8) and 10 μM nigericin [11]. Buffering
capacity of cells was determined as described earlier [11,19] and
proton ﬂux via NHE1 protein was determined using the slope of the
ﬁrst 20 seconds of the recovery period. Other kinetic parameters of
the Na+/H+ exchanger were determined essentially as described
earlier [11,19]. Because we earlier found that growth conditions
affect the absolute level of NHE1 activity, experiments comparing
the activities of wild type and NHE1 mutants were done in pairs or
groups, so that all comparisons of activity were done with cells were
grown to the same degree of conﬂuence andwith the samemedia. For
some experiments Na+ and Li+ concentrations were varied while
maintaining osmolarity with N-methyl-D-glucamine. In other experi-
ments we investigated the inhibitor sensitivity of some mutants. Cells
were treated with the highly selective NHE1 inhibitor EMD87580 at
varying concentrations [20]. EMD87580 was dissolved in water and
the inhibitory effect of EMD87580 was measured using a dual-pulse
acidiﬁcation assay. In this assay, cells were treated with ammonium
chloride two times as described above and allowed to recover in NaCl
containing medium following each pulse. The ﬁrst pulse and recovery
is in the absence of EMD87580 while the second pulse recovery is inthe presence of inhibitor. To calculate residual activity during recovery
from acidosis the following formula was used
k residual activity =
proton flux afterðReagentÞ
proton flux w=oðReagentÞ × 100k
The rate of recovery from acid load is compared±inhibitor.
Results are shown as mean±SE and statistical signiﬁcance was
determined using a Wilcoxon–Mann–Whitney Rank Sum test. IC50s
were calculated as described earlier [21]. Differences between IC50s of
mutants was determined by a Holm–Sidak post hoc test.
2.7. Peptide synthesis and puriﬁcation
An EL2 peptide consisting of amino acids Gly150 to Phe155 of
human NHE1 (sequence, GETPPF; acetyl-capped N terminus, amide-
capped C terminus) was synthesized by the Alberta Peptide Institute
at N95% purity. Purity was assessed by HPLC and identity conﬁrmed
using sequential assignment of NMR data and by matrix-assisted laser
desorption ionization mass spectroscopy.
2.8. NMR spectroscopy and structure calculations
Samples for NMR spectroscopy contained 5mM EL2 peptide, 0.1 M
KCl, 10 mM imidazole, and 0.25 mM DSS-d6 in 95% H20/5% D20. The
pH was adjusted to 5 without consideration of deuterium effects on
the pH electrode. 1D 1H NMR spectra and 2D 1H–1H ROESY (250 ms
mix) spectra were obtained on the NANUC Varian 800 MHz
spectrometer. 2D TOCSY (60 ms mix) and natural abundance 13C
HSQC spectra were obtained on a Varian 500 MHz spectrometer.
Spectra were processed using NMRPipe [22] and peak picking and
assignment were done manually in NMRVIEW [23]. Distance
restraints for structure calculation were obtained from the ROESY
spectrum peaks. Peaks were calibrated based on peak intensity, and
sorted into distance ranges of either strong (1.8–2.8 Å´), medium (1.8–
3.2 Å´) or weak (1.8–5.0 Å´). Structures were calculated in the python
scripting interface of XPLOR-NIH 2.19 [24]. Several rounds of
simulated annealing and reﬁnement were performed. Initially,
restraints with frequent violations greater than 0.5 Å´ were examined,
and either lengthened or modiﬁed. In later rounds, violations greater
than 0.1 Å´ were examined. 50 structures were calculated each round,
and the structureswith noNOEviolations greater than0.1 Å´ were kept.
3. Results
Fig. 1 illustrates a general model of the Na+/H+ exchanger [15] and
an enlargement of TMIII-EL2-TM IV is also shown. Based on our and
other reports of the importance of TM IV we conducted further
investigation of this region. In particular, we characterized amino
acids Pro153, Pro154 and Phe155 of the extracellular loop 2. Prolines may
be particularly important in membrane proteins, disrupting α-helices,
and introducing ﬂexibility [17,25]. Mutations were made to an
expression plasmid containing a full length, tagged human NHE1
isoform of the Na+/H+ exchanger. Initially, experiments determined
whether these mutant forms of the Na+/H+ exchanger expressed and
targeted properly. Western blotting using anti tag (HA) antibodies was
used to characterize the proteins expression (Fig. 2A). AP1 cells
transfected with plasmid containing the HA-tagged wild type NHE1
resulted in the presence of an immunoreactive species of 110 kDa, plus a
smaller band at 95 kDa that represents an immature form of the
exchanger that is not fully glycosylated [16]. Untransfected cells (Lane 1,
AP1) showno such immunoreactivity. The level of expression relative to
the wild type Na+/H+ exchanger is shown below each mutant. The
Pro153Alamutant had signiﬁcantly decreased expression (Pb0.05), 78%
of the wild type, while the protein level of Pro154 and Phe155Ala
mutants was not signiﬁcantly different than that of wild type.
Fig. 2. Western blot analysis of cell extracts from stable cell lines expressing wild type
and mutants of NHE1. (A) Western blot of cell extracts from AP-1 cells transfected with
HA-tagged wild-type NHE1 (WT) or transfected with NHE1 mutants Pro153Ala
(P153A), Pro154Ala (P154A) and Phe155Ala (F155A). Anti-HA antibody was used to
detect tagged NHE1 protein and the amount of NHE1 protein was quantiﬁed. Numbers
underneath the lanes indicate the mean value (±SD) of the sum of densitometric scans
of both 110 kDa and 95 kDa bands relative to wild-type NHE1 for at least three
experiments. (B) Plasma membrane targeting of the Na+/H+ exchanger in AP-1 cells
transfected with wild-type NHE1 (WT) and with the NHE1 mutants Pro153Ala
(P153A), Pro154Ala (P154A) and Phe155Ala (F155A). Sulfo-NHS-SS-biotin-treated
cells were lysed and their proteins were solubilized and subsequently treated with
streptavidin agarose to bind labeled protein as described in Materials and methods.
Equal samples of total lysates (T) and unbound (representing intracellular) lysates (I)
were run on SDS-PAGE and blotted with anti-HA antibody to identify NHE1 Protein
Non-speciﬁc (CT) refers to an experiment in which non-speciﬁc binding to
streptavidin-agarose beads wasmeasured by following the standard procedure without
labeling cells with biotin. The percent of the total NHE1 protein localized to the plasma
membrane is indicated. The results are mean±standard error for at least 4
determinations. ⁎ Indicates signiﬁcantly reduced plasma membrane targeting in
comparison to wild type NHE1 (Pb0.05).
Fig. 3.Na+/H+ exchanger activity of AP1 cells stably transfected with control and NHE1
mutants. NHE activity was measured in 135 mM NaCl as described in Materials and
methods in stable cell lines expressing wild type NHE1 (WT) and NHE1mutant proteins
Pro153Ala (P153A), Pro154Ala (P154A) and Phe155Ala (F155A). Initial pH's of the
mutant cells after acidiﬁcation were 6.04, 6.06, 6.07 and 6.07 for the mutant cell lines,
respectively, and were not signiﬁcantly different from one another. Grey bars indicated
uncorrected values of NHE1 activity. Black bars indicate activity after correction for the
level of expression and surface targeting relative to the WT. Results are relative to the
value of the wild type NHE1 protein and are the mean±the S.E. of 5–7 determinations
from two independently made cell lines. ⁎ Indicates signiﬁcantly different from thewild
type at Pb0.01.
Fig. 4. Effect of EMD87580 on activity of wild type and NHE1 mutant proteins. NHE1
activity was determined in 135 mM NaCl. The activity was determined in a dual pulse
assay in which cells were acidiﬁed twice and allowed to recover twice. The relative
rates of proton ﬂux were determined and the second pulse in the presence of 0.7 μM
EMD87589, was compared to the ﬁrst. NHE1 (WT); Pro153Ala (P153A); Pro154Ala
(P154A); Phe155Ala (F155A). The results are the mean±the S.E. of at least 12
determinations. ⁎ Indicates signiﬁcantly different from the wild type at Pb0.05.
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targeting of the Na+/H+ exchanger [16]. Therefore, we examined
intracellular targeting of the NHE1 expressing cell lines. After cells
were treated with sulfo-NHS-SS-biotin, labeled proteins of lysates
were bound to streptavidin-agarose beads. To identify NHE1 protein,
we usedWestern blotting with anti-HA antibody and examined equal
amounts of total cell lysates and unbound lysates. This revealed the
relative amounts of tagged intracellular NHE1 protein. Fig. 2B
illustrates examples of the results and a summary of at least 4
experiments. A majority of the wild-type NHE1 protein was present
on the plasma membrane, Pro154Ala and Phe155Ala proteins had
similar level of plasma membrane localization in comparison with the
wild type protein. However, Pro153Ala did have slightly, but
signiﬁcantly reduced plasma membrane targeting compared to the
wild-type NHE1 protein. We noted that non-speciﬁc binding of
proteins to streptavidin agarose beads was approximately 5%,
therefore, our values of NHE1 on the cell surface are an overestimate
by this amount. We also analyzed the subcellular distribution of the
fully glycosylated and partially or de- glycosylated forms of NHE1
separately (Supplementary Table 1). This analysis showed that the
partially glycosylated form of NHE1 was mostly intracellular and the
surface targeting of fully glycosylated NHE1 was therefore 5–10%
higher than the values given in Fig. 2B. The P153A mutant, was still
signiﬁcantly decreased in its targeting relative to the other mutants.
Since we observed that these mutations did not greatly impair
expression or surface targeting of the protein, we examined the
activity of the mutant exchangers in comparison with the wild type
protein. Fig. 3 shows both the uncorrected activity (grey bars) and the
activity corrected for expression and surface processing (black bars)
relative to wild-type NHE1 for the three mutants. All three mutantshad signiﬁcantly decreased activity relative to wild-type NHE1. The
Pro153Ala mutant was decreased the least of these mutants. When
correcting for expression levels and targeting this decrease was
reduced.
EMD87580 is a potent and selective NHE1 inhibitor [20].
Alterations in sensitivity to inhibition have been reported earlier
upon mutation of amino acids in transmembrane segments of NHE1
and may indicate important alterations in cation binding or
coordination by the protein [2,26]. To determine whether alterations
in NHE1 inhibitor sensitivity occurred with the amino acids mutated
in this study, we initially tested the effect of 0.7 μM EMD87580 on the
mutants. We have earlier determined that this concentration of
EMD87580 inhibits approximately 40–50% of the activity of the NHE1
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average of less than 0.04 pH units between wild type and mutants.
The difference between the starting pH of the ﬁrst and second pulse
varied nominally by an average of 0.009 pH units. Fig. 4 shows the
results comparing the rate of proton ﬂux of the second pulse in the
presence of EMD87580 with that of the proton ﬂux in the absence of
EMD87580. The Pro154Ala mutant had decreased level of inhibition
by EMD87580 in comparison to the wild type. To further investigate
these results in more detail we characterized the effectiveness of a
wide range of concentrations of EMD87580 on the mutant NHE1
proteins relative to the control (not shown). In these tests there was
also no signiﬁcant difference in the starting pHi of recovery or
between the starting pHi in the ﬁrst and second pulse of recovery. The
value of wild type NHE1 IC50was 0.64 μM. The IC50s of Pro153Ala and
Pro155Ala were 0.84 and 0.83 μM respectively, which were not
signiﬁcantly different from the wild type. The resistance of the
Pro154Ala mutant was increased more than that of the others and it
had an IC50 of 1.27 μM, a two-fold increase over that of the wild type
and was the only statistically signiﬁcant change (Pb0.05).
To gain insights into the nature of the effects of the mutations, we
examined their afﬁnity for Na+ or Li+ relative to that of the wild type.
Ammonium chloride was used to induce acidiﬁcation and varying
levels of NaCl or LiCl were used to allow recovery. Differences inFig. 5. Effect of different Na+ and Li+ concentration on activity of wild type and NHE1
mutant proteins. NHE1 activity was determined as described in the “Materials and
methods” and is shown without correction for expression levels or targeting. (A) Effect of
different Na+ concentrations (10, 20, 40, 70, 100 and 135mM) onNHE1 activity. (B) Effect
of different Li+ concentrations (10, 20, 40, 70, 100 and 135mM) on NHE1 activity. All the
results are the mean±the S.E. of at least 8 determinations.activity between the groups were not due to differences in initial pH
following acidiﬁcation induced by ammonium chloride. Fig. 5A
illustrates the effects of altering the Na+ levels on the activity of the
protein. All the mutants had less activity than wild type. The
Pro153Ala had the most activity of the mutants while the Pro154Ala
and Phe155Ala mutants were reduced more in activation in
comparison with the wild type. The Km for the wild type, Pro153Ala,
Pro154Ala and Phe155Ala was 73.3, 74.2, 66.6, and 72.3 mM
respectively, which indicated that the afﬁnity for Na+ was not greatly
altered compared to the wild type. The Vmax values of the wild type
and Pro153Ala, Pro154Ala and Phe155Ala mutants were 196, 138, 111
and 56 mM/min, respectively, suggesting substantial apparent
decreases for the mutants. It should be noted that saturating
concentrations of NaCl were not necessarily reached due to osmotic
considerations with the cells, so the Vmax values should be noted as
estimates only.
Similar experiments were done using LiCl instead of NaCl (Fig. 5B).
In this case, the proton transport rates were much lower than that of
Na+. The Vmax for wild type, Pro153Ala, Pro154Ala and Phe155Ala
mutants was 66, 71, 51 and 19 mM/min, respectively, indicating a
possible decrease in the Vmax of transport for the Pro154Ala mutant
and a reduction in activity in the Phe155Ala mutant. The Km for these
proteins was 22, 29, 30 and 23 mM, respectively, which again
illustrated that the Li+ transport afﬁnity of the Pro154Ala mutant was
not greatly altered. It was noted that for the wild type NHE1 protein
and the three mutants, by the LiCl concentration of 70 mM activity
was maximal and further increases in LiCl did not stimulate NHE1
activity further. It has been previously reported that lower concentra-
tions of LiCl are required for activation of NHE1 in comparison to NaCl
concentrations [21,27].
The peptide representing the predicted extracellular loop 2 of
NHE1 was synthesized with an N-terminal acetate and C-terminal
amide cap to remove charges at the termini that would not be present
in the sequence when in the full protein. NMR spectra were acquired
with a sample containing 0.1 M KCl; however, the extracellular loop
would normally be exposed to a higher concentration of Na+
compared to K+ in its native environment. The 1D NMR spectra of a
single sample in 0.1 MNaCl was the same as spectra in 0.1 M KCl (data
not shown), so the spectra frommultiple samples with KCl were used
for analysis.
Trial 1D NMR spectra were acquired at 10, 20, and 30 °C. Spectra
acquired at 10 °C allowed for better resolution of peaks near the water
peak, and the 2D spectra for analysis were obtained at this
temperature. It is also expected that lower temperatures would
stabilize any nascent structure in the peptide. Due to the small
molecular weight of the peptide (about 700 Da), NOESY spectraFig. 6. Region of 1D NMR spectrum showing cis–trans isomerization in the EL2 peptide.
The threonine methyl region from the 1D spectrum of the EL2 peptide is shown, with
the methyl peaks labeled with the conformation of the peptide it belongs to: trans–
trans (tt), trans–cis (tc), or cis–trans (ct). The relative percentages of each from
integration of the peaks are shown in brackets.
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was obtained instead.
Sequential assignment was performed using the TOCSY and ROESY
spectra. Spectra showed triplicate peaks from all of the residues
except the N-terminal glycine, resulting from the slow cis–trans
isomerization of the peptide bonds preceding the two prolines. Fig. 6
shows a portion of the 1D spectrum containing the Thr methyl peaks
from the three conformations. Integration of the threonine methyl
peaks in the 1D spectrum gives percentages of about 73, 19.5, 7.5% for
the three conformations. X-Pro peptide bond conformations were
determined from the X-Hα to Pro Hα or Hδ connectivities. The major
conformation was identiﬁed as trans–trans, and the second as trans–
cis. The third conformation (cis–trans) was not investigated further
due to spectral overlap and the low intensity of the peaks. A cis–cis
conformation could not be seen.
Contacts from the ROESY spectra between Pro153 and Phe155
suggest a beta turn in the trans–cis conformation. A strong Pro Hα-
Phe HN contact can be seen, which would suggest a beta-turn at
residues T152PPF155. Other contacts, between the Pro and Phe rings,
suggest there could be an interaction between them, possibly a CH-π
interaction, which could help stabilize the cis bond and promote the
turn formation [28]. There are also weak contacts between the Phe
and Glu residues, which could result from the turn formation. The
interaction of the Phe and Pro rings is supported by the splitting of the
Phe Hβ proton peak, fromwhich 2 different values of the 3Jαβ coupling
constants can be measured (∼5 and 12 Hz), suggesting restricted
movement of the side chain. In contrast, the trans–trans conformation
has only a single peakwith a 3Jαβ of ∼7.6 Hz. There do not appear to be
any contacts in the trans–trans conformation that support formation
of any secondary structure.
Structures were calculated separately for the trans–trans and
trans–cis conformations. Structures for the third conformation were
not calculated, due to the lack of interresidue restraints. Secondary
structure assignment using the PROMOTIF v2.0 [29] suggests that
beta-turns occur in some of the structures calculated in both the
trans–trans and trans–cis peptides. 35 of 46 trans–cis peptide
structures contained beta-turns at T152PPF155, with some structures
showing close contacts between the Phe and Pro rings. The ﬂexible
nature of a small peptide would allow it to sample a large number of
conformations, with the result that the spectra would show an
average of these conformations. The restraints obtained from theFig. 7. Structures of EL2 peptide calculated from ROESY distance restraints. Single
structures from the ensembles of structures calculated for the (a) trans–trans and (b)
trans–cis conformation of the peptide.ROESY spectrum are thus also an average of the conformations the
peptide is experiencing. The variation in the structures could be
reﬂective of this ﬂexibility, or of the low number of intermolecular
restraints available for structure calculation, but the presence of
crosspeaks in the ROSEY still suggest that a turn is being formed. 24 of
the 44 structures in the trans–trans conformer contained beta-turns at
G150ETP153, however, due to a lack of appropriate interresidue
contacts, it is unlikely that a stable turn is being formed. Fig. 7
shows a calculated structure for each conformation.
4. Discussion
Studies on themembrane domain of the NHE1 isoform of the Na+/
H+ exchanger have suggested that speciﬁc amino acids of the TM
segments IV, VII, IX and XI are critical in the function of the protein
[2,18,30,31]. Speciﬁcmutations of TM IV in particular can alter theNa+
afﬁnity and sensitivity to inhibition [2,32]. It is known that the loop
regions at either end of transmembrane segments also contain
residues that are important for NHE1 function [2,14,33]. In potassium
channels and in the E. coli Na+/H+ antiporter NhaA, residues
extending past the plane of the lipid bilayer have also been suggested
to be important in attraction of cations, facilitating their transport
[34,35]. Studies have suggested TM IV and associated amino acids are
important in cation coordination and inhibitor efﬁcacy
[14,16,27,32,36]. In the present study we therefore further character-
ized three residues of the extracellular loop 2 involved in the NHE1
structure, function and drug recognition.
Of the amino acids 153–155 it was clear that both Pro154 and
Phe155 are critical to NHE1 function. Though mutation of either
residue did not cause a great aberration in either targeting or
expression of the protein, mutation of either causes nominally larger
decreases in activity than mutation of Pro153. The only signiﬁcant
effects on resistance to inhibition by EMD87580 were via mutation of
Pro154, further suggesting it had a critical role in NHE1 function. Fig.
8 shows a comparison of the amino acid sequences of EL2 and nearby
sequences of TM III and IV. Pro154 was completely conserved in all
vertebrate species examined while Phe155 was more variable and
Pro153 was usually, but not always, conserved. Phe155 was not well
conserved, though a bulky hydrophobic residuewas always present in
this position. Neither EL2 nor this general region were conserved at all
in invertebrate species such as Drosophila. It is generally agreed that
conservation of a particular region or of an amino acid is suggestive of
a more critical function, which is in agreement with our results. Of the
other amino acids studied, the Pro153Ala mutation decreased both
the protein expression level and the surface targeting comparing with
the wild type. This result indicated that although Pro153 is not as
critical to NHE1 activity as Pro154 and Phe155, its mutation affects
NHE1 expression levels and targeting.
In the case of Phe155Ala mutation, there were no signiﬁcant
changes among the protein expression level and surface targeting
however, activity was reduced and EMD87580 sensitivity was slightly
decreased. Thus the Phe155 residue was not essential for NHE1
structure and function but mutation to Ala resulted in a decrease in
activity of NHE1. It may be that a bulky hydrophobic residue is
required at this position for full function (Fig. 8).
An earlier report demonstrated that in rat NHE1, the dual
mutation Pro157Ser/Pro158Phe (corresponding to human Pro153/
Pro154) markedly reduced the sensitivity to another NHE1 inhibitor
EIPA, 7 fold [14]. We observed that mutation of either residue had a
smaller affect on inhibitor sensitivity than that study. This could be
due to either the different inhibitor used, EMD87580 vs. EIPA, or
because we mutated individual amino acids and not both prolines
simultaneously. The dual Pro157Ser/Pro158Phe reported earlier [14]
did not affect Na+ afﬁnity but did affect maximal activity of the
protein. Our study found that mutation of Pro154 had a marked
inhibitory effect on cation afﬁnity in addition to transport rate, while
Fig. 8. Alignment of amino acid sequences of EL2 and surrounding region of various NHE1 proteins. The alignment wasmade either manually or using the program “DNA Strider.” The
EL2 region is shaded where identical to that of human NHE1. References [44–50] are indicated and where they were not available the accession number of the protein sequence
was given.
2487B.L. Lee et al. / Biochimica et Biophysica Acta 1788 (2009) 2481–2488mutation of Pro153 did not. Our results therefore suggest the second
Pro of the pair in EL2 is more important than the ﬁrst in determining
vertebrate NHE1 function.
Because Pro residues are known to signiﬁcantly inﬂuence the
secondary conformations of proteins, they may contribute to the
differential drug sensitivity of the NHE isoforms. Prolines tend to be
helix breakers [25,37] within TM segments. In addition it has been
suggested that membrane proteins accumulate Pro residues at the
end of their TM segments in order to expose select amino acids at the
interface of molecular recognition events, while allowing stable
association and native folding [38]. It is also interesting to note that
TM IV itself has a pair of Pro residues, Pro167 and Pro168 that are
critical to function of the protein [17]. However in contrast to these
prolines, the requirement for a Pro at position 153 and 154 is not
absolute. Substitutions could be made that retained NHE1 activity.
Proline residues have a high preference of forming the cis isomer
of the peptide bond preceding it due to the cyclic nature of proline,
relative to other amino acids, which are mainly in the trans form [39].
The structure of the peptide exhibited at least three conformations
observed in solution due to the cis–trans isomerization of the peptide
bonds preceding the proline residues, with a possible fourth
conformation not observed, due to a low population and/or peak
overlap. When in the trans–cis conformation, the peptide is able to
form a beta turn, and this suggests that the sequence in the full protein
could also adopt a turn. Also, the sequence involved appears to be
favorable in forming a turn with a cis–peptide bond [40]. The
formation of a turn would support its predicted location in the
topologymodel of NHE1, as a short loop between two transmembrane
helices. The beta-turn structure allows for a 180-degree reversal of
peptide backbone facilitating re-entry into the membrane bilayer. A
short peptide would be quite ﬂexible, with a large population of the
peptide in a trans–trans and extended conformation, so the actual
conformation in the protein would likely also depend on the distances
between the ends of the two connecting helices as well as its
interactions with residues nearby in the protein.
The ability of the peptide sequence to adopt a turn conformation
might explain the results in the mutagenesis experiments. If the
sequence forms a turn in the full protein, then the mutation of the
critical Pro154 to Ala could make the formation of the turn less
favorable, due to the decreased preference for the cis bond previous to
the mutated residue. Conformational changes in the TM helix packing
have been implicated in the bacterial Na+/H+ exchanger activation
[41,42] and dynamics simulations suggest that the sequences of
interhelical loops may be involved in stabilizing helix interactions
[43]. The change from a beta-turn to an extended conformation in the
extracellular loop could affect the packing of the transmembrane
helices, which could result in a less active protein. The observed
decrease in inhibition by EMD87580 could be due to a decrease in
binding of the inhibitor, due to a change in structure of its binding
pocket on mutation of the loop region. The drug could be binding in a
pocket that includes the loop, so that a mutation would change thestructure of the binding pocket, or the drug could bind in a pocket
which is indirectly affected by mutations in the loop which could
affect the helix packing.
In summary our results show that EL2 is important in NHE1
function, likely playing a role in maintaining appropriate conforma-
tion of the protein, possibly by inﬂuencing helix packing. Pro154 and
Phe155 are both critical residues of this extracellular loop though
signiﬁcant function of the protein still remained after their mutation.
Future studies will characterize the role of other extracellular loops of
the protein.
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